surmount-1 tirzepatide trial obesity without diabetes A 72-week trial compared the two leading GLP-1 medications in adults with obesity (no diabetes). SURMOUNT 1 // Three-Year Obesty
Pay in 4 interest-free payments of $5.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5


01200-X/asset/1ec2c191-5a64-4856-842f-bfa65a8fabc6/main.assets/gr2.jpg)


























